The Seaport criteria for myocarditis

Affiliations

¹ Office of the Chief Medical Examiner, New York, NY, USA.
² Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
³ University Center of Legal Medicine Lausanne - Geneva, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. katarzyna.michaud@chuv.ch.

Barbara Sampson et al. Forensic Sci Med Pathol. 2025.

. 2025 Oct 15.

doi: 10.1007/s12024-025-01103-7. Online ahead of print.

¹ Office of the Chief Medical Examiner, New York, NY, USA.
² Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
³ University Center of Legal Medicine Lausanne - Geneva, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. katarzyna.michaud@chuv.ch.

No abstract available

Conflict of interest statement

Declarations. Conflict of interest: Authors declare no conflict of interest.

1. Aretz H, Billingham ME, Edwards W, Factor S, Fallon J, Fenoglio JJ, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3–14. - PubMed
1. Maleszewski JJ, Banner J, de Boer H, De Gaspari M, Fishbein MC, Parsons S, et al. Lymphocytic myocarditis: a histopathologic definition and classification from the society for cardiovascular pathology and association for European cardiovascular pathology. Part II: surgical and autopsy specimens. Cardiovasc Pathol. 2025;78:107748. - DOI - PubMed
1. Halushka MK, Giulia dA, Bois MC, Fallon JT, Giordano C, Klingel K et al. Lymphocytic myocarditis: a histopathologic definition and classification from the society for cardiovascular pathology and association for European cardiovascular pathology. I: Endomyocardial Biopsy. Cardiovasc Pathol. 2025;78:107759.